These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 3110272)

  • 21. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon.
    Means RT; Dessypris EN; Krantz SB
    J Cell Physiol; 1992 Jan; 150(1):59-64. PubMed ID: 1730787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines.
    Hancock WW; Muller WA; Cotran RS
    J Immunol; 1987 Jan; 138(1):185-91. PubMed ID: 3097144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells.
    Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL
    Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
    Broxmeyer HE; Cooper S; Rubin BY; Taylor MW
    J Immunol; 1985 Oct; 135(4):2502-6. PubMed ID: 3928752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for effects of interleukin 4 (B cell stimulatory factor 1) on macrophages: enhancement of antigen presenting ability of bone marrow-derived macrophages.
    Zlotnik A; Fischer M; Roehm N; Zipori D
    J Immunol; 1987 Jun; 138(12):4275-9. PubMed ID: 3495588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-1 inhibits B cell differentiation in long term bone marrow cultures.
    Dorshkind K
    J Immunol; 1988 Jul; 141(2):531-8. PubMed ID: 3260256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirement for delivery of signals by physical interaction and soluble factors from accessory cells in the induction of receptor-mediated T cell proliferation. Effectiveness of IFN-gamma modulation of accessory cells for physical interaction with T cells.
    Kawakami K; Yamamoto Y; Kakimoto K; Onoue K
    J Immunol; 1989 Mar; 142(6):1818-25. PubMed ID: 2493498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receptor-specific inhibition of bone marrow erythropoiesis by recombinant DNA-derived interleukin-2.
    Burdach SE; Levitt LJ
    Blood; 1987 May; 69(5):1368-75. PubMed ID: 3105620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Requirement for three distinct lymphokines for the induction of cytotoxic T lymphocytes from thymocytes.
    Takai Y; Herrmann SH; Greenstein JL; Spitalny GL; Burakoff SJ
    J Immunol; 1986 Dec; 137(11):3494-500. PubMed ID: 3097123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of natural killer cells, in comparison with T lymphocytes and monocytes, in the regulation of normal human megakaryocytopoiesis in vitro.
    Gewirtz AM; Xu WY; Mangan KF
    J Immunol; 1987 Nov; 139(9):2915-24. PubMed ID: 3117880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo.
    Broxmeyer HE; Gentile P; Cooper S; Lu L; Juliano L; Piacibello W; Meyers PA; Cavanna F
    Blood Cells; 1984; 10(2-3):397-426. PubMed ID: 6543656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro analysis of the interactions of recombinant IL-2 with regenerating lymphoid and myeloid cells after allogeneic marrow transplantation.
    Heslop HE; Price GM; Prentice HG; Cordingley FT; Webster AD; Hoffbrand AV; Brenner MK
    J Immunol; 1988 May; 140(10):3461-6. PubMed ID: 3283234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Ia antigen expression in macrophages derived from bone marrow cells cultured in granulocyte-macrophage colony-stimulating factor or macrophage colony-stimulating factor.
    Falk LA; Wahl LM; Vogel SN
    J Immunol; 1988 Apr; 140(8):2652-60. PubMed ID: 3128601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses.
    Scheurich P; Thoma B; Ucer U; Pfizenmaier K
    J Immunol; 1987 Mar; 138(6):1786-90. PubMed ID: 3029221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ligation of CD28 on resting T cells by its ligand B7 results in the induction of both Th1- and Th2-type cytokines.
    Walter H; Schepensn S; Van Wauwe J; de Boer M
    Eur Cytokine Netw; 1994; 5(1):13-21. PubMed ID: 7519453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development.
    Wang CQ; Udupa KB; Lipschitz DA
    J Cell Physiol; 1995 Jan; 162(1):134-8. PubMed ID: 7814445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of human bone marrow with recombinant placenta immunoregulator ferritin results in myelopoiesis and T-cell suppression through modulation of the cytokine-chemokine networks.
    Moroz C; Grunspan A; Zahalka MA; Traub L; Kodman Y; Yaniv I
    Exp Hematol; 2006 Feb; 34(2):159-66. PubMed ID: 16459184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinction between antigen receptor and IL 2 receptor triggering events in the activation of alloreactive T cell clones with calcium ionophore and phorbol ester.
    Albert F; Hua C; Truneh A; Pierres M; Schmitt-Verhulst AM
    J Immunol; 1985 Jun; 134(6):3649-55. PubMed ID: 3921610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.